ORBIMED ADVISORS LLC Q3 2024 Filing
Filed November 14, 2024
Portfolio Value
$5.5B
Holdings
113
Report Date
Q3 2024
Filing Type
13F-HR
All Holdings (113 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | EWTXEDGEWISE THERAPEUTICS INC | 15,021,721 | $400.9B | 7284.97% | |
| 2 | SVASINOVAC BIOTECH LTD | 2,718,735 | $340.0B | 6177.87% | |
| 3 | LLYELI LILLY & CO | 337,600 | $299.1B | 5434.58% | |
| 4 | BSXBOSTON SCIENTIFIC CORP | 3,273,000 | $274.3B | 4983.67% | |
| 5 | ISRGINTUITIVE SURGICAL INC | 433,800 | $213.1B | 3872.30% | |
| 6 | ELVNENLIVEN THERAPEUTICS INC | 7,959,538 | $203.3B | 3693.76% | |
| 7 | BIIBBIOGEN INC | 813,000 | $157.6B | 2863.48% | |
| 8 | MRKMERCK & CO INC | 1,316,000 | $149.4B | 2715.44% | |
| 9 | THCTENET HEALTHCARE CORP | 782,000 | $130.0B | 2361.55% | |
| 10 | SRPTSAREPTA THERAPEUTICS INC | 1,004,500 | $125.5B | 2279.49% | Call |
| 11 | SYKSTRYKER CORPORATION | 344,400 | $124.4B | 2260.70% | |
| 12 | SPRYARS PHARMACEUTICALS INC | 8,288,510 | $120.2B | 2183.76% | |
| 13 | ARGXARGENX SE | 204,500 | $110.9B | 2014.26% | |
| 14 | UNHUNITEDHEALTH GROUP INC | 179,000 | $104.7B | 1901.65% | |
| 15 | QTTBQ32 BIO INC | 2,252,987 | $100.5B | 1826.62% | |
| 16 | MBXMBX BIOSCIENCES INC | 3,812,215 | $99.0B | 1799.60% | |
| 17 | ISIIONIS PHARMACEUTICALS INC | 2,324,447 | $93.1B | 1691.96% | |
| 18 | IRONDISC MEDICINE INC | 1,785,571 | $87.7B | 1594.31% | |
| 19 | NTRANATERA INC | 687,500 | $87.3B | 1585.86% | |
| 20 | AMGNAMGEN INC | 252,300 | $81.3B | 1477.12% | |
| 21 | THRDTHIRD HARMONIC BIO INC | 5,779,071 | $78.3B | 1422.84% | |
| 22 | ITGRINTEGER HLDGS CORP | 575,000 | $74.8B | 1358.22% | |
| 23 | AVBPARRIVENT BIOPHARMA INC | 3,027,328 | $71.1B | 1292.67% | |
| 24 | VRTXVERTEX PHARMACEUTICALS INC | 151,000 | $70.2B | 1276.04% | |
| 25 | ALNYALNYLAM PHARMACEUTICALS INC | 250,300 | $68.8B | 1250.84% | |
| 26 | TERNTERNS PHARMACEUTICALS INC | 7,562,971 | $63.1B | 1146.09% | |
| 27 | KROSKEROS THERAPEUTICS INC | 1,018,734 | $59.2B | 1074.91% | |
| 28 | JANXJANUX THERAPEUTICS INC | 1,258,566 | $57.2B | 1038.91% | |
| 29 | ELVELEVANCE HEALTH INC | 106,200 | $55.2B | 1003.43% | |
| 30 | EVHEVOLENT HEALTH INC | 1,923,515 | $54.4B | 988.40% | Call |
| 31 | CRNXCRINETICS PHARMACEUTICALS IN | 1,050,055 | $53.7B | 974.97% | |
| 32 | RNAAVIDITY BIOSCIENCES INC | 1,144,805 | $52.6B | 955.40% | Call |
| 33 | TMOTHERMO FISHER SCIENTIFIC INC | 84,400 | $52.2B | 948.62% | |
| 34 | SIBNSI-BONE INC | 3,555,801 | $49.7B | 903.24% | Call |
| 35 | XTNTXTANT MED HLDGS INC | 73,114,592 | $49.4B | 898.07% | |
| 36 | REGNREGENERON PHARMACEUTICALS | 45,200 | $47.5B | 863.38% | |
| 37 | EXASEXACT SCIENCES CORP | 679,816 | $46.3B | 841.44% | |
| 38 | SWTXSPRINGWORKS THERAPEUTICS INC | 1,390,631 | $44.6B | 809.59% | |
| 39 | PCVXVAXCYTE INC | 387,000 | $44.2B | 803.53% | |
| 40 | CMPXCOMPASS THERAPEUTICS INC | 22,362,850 | $41.1B | 747.66% | |
| 41 | CYTKCYTOKINETICS INC | 766,906 | $40.5B | 735.76% | |
| 42 | SNDXSYNDAX PHARMACEUTICALS INC | 1,925,300 | $37.1B | 673.42% | |
| 43 | CRVSCORVUS PHARMACEUTICALS INC | 6,943,654 | $36.7B | 666.16% | |
| 44 | APLSAPELLIS PHARMACEUTICALS INC | 1,270,400 | $36.6B | 665.73% | |
| 45 | XENEXENON PHARMACEUTICALS INC | 911,420 | $35.9B | 651.99% | |
| 46 | UHSUNIVERSAL HLTH SVCS INC | 156,000 | $35.7B | 649.14% | |
| 47 | ICLRICON PLC | 123,900 | $35.6B | 646.82% | |
| 48 | NBIXNEUROCRINE BIOSCIENCES INC | 302,220 | $34.8B | 632.72% | |
| 49 | VERAVERA THERAPEUTICS INC | 675,872 | $29.9B | 542.81% | |
| 50 | BIOABIOAGE LABS INC | 1,423,470 | $29.6B | 537.99% | |
| 51 | SCPHSCPHARMACEUTICALS INC | 6,059,528 | $27.6B | 502.07% | |
| 52 | VIRVIR BIOTECHNOLOGY INC | 3,573,000 | $26.8B | 486.27% | |
| 53 | PHATPHATHOM PHARMACEUTICALS INC | 1,449,073 | $26.2B | 476.05% | |
| 54 | CGONCG ONCOLOGY INC | 691,114 | $26.1B | 473.80% | |
| 55 | CCCCC4 THERAPEUTICS INC | 4,527,900 | $25.8B | 468.96% | Call |
| 56 | DYNDYNE THERAPEUTICS INC | 708,400 | $25.4B | 462.35% | |
| 57 | MLYSMINERALYS THERAPEUTICS INC | 2,002,939 | $24.3B | 440.73% | |
| 58 | NPCENEUROPACE INC | 3,406,335 | $23.7B | 431.40% | |
| 59 | IMTXIMMATICS N.V | 2,006,381 | $22.9B | 415.97% | |
| 60 | RYTMRHYTHM PHARMACEUTICALS INC | 435,900 | $22.8B | 414.95% | |
| 61 | PRLDPRELUDE THERAPEUTICS INC | 10,909,256 | $22.6B | 410.32% | |
| 62 | APGEAPOGEE THERAPEUTICS INC | 379,130 | $22.3B | 404.65% | |
| 63 | NMRANEUMORA THERAPEUTICS INC. | 1,500,000 | $19.8B | 360.04% | |
| 64 | SLRNACELYRIN INC | 4,001,711 | $19.7B | 358.47% | |
| 65 | CRBPCORBUS PHARMACEUTICALS HLDGS | 912,552 | $18.8B | 342.07% | |
| 66 | TYRATYRA BIOSCIENCES INC | 768,638 | $18.1B | 328.35% | |
| 67 | CGEMCULLINAN THERAPEUTICS INC | 1,070,055 | $17.9B | 325.48% | |
| 68 | LXRXLEXICON PHARMACEUTICALS INC | 11,024,000 | $17.3B | 314.48% | |
| 69 | GPCRSTRUCTURE THERAPEUTICS INC | 383,705 | $16.8B | 306.00% | |
| 70 | TORCEURADICET BIO INC | 11,447,140 | $16.5B | 299.52% | |
| 71 | MEDPMEDPACE HLDGS INC | 44,900 | $15.0B | 272.33% | |
| 72 | ADCTADC THERAPEUTICS SA | 4,533,801 | $14.3B | 259.50% | |
| 73 | GILDGILEAD SCIENCES INC | 151,700 | $12.7B | 231.10% | |
| 74 | BNTXBIONTECH SE | 103,000 | $12.2B | 222.28% | |
| 75 | ACADACADIA PHARMACEUTICALS INC | 764,600 | $11.8B | 213.67% | |
| 76 | IMAPRELUDE THERAPEUTICS INC | 5,680,186 | $11.8B | 213.64% | |
| 77 | RPTXREPARE THERAPEUTICS INC | 3,322,488 | $11.4B | 207.67% | |
| 78 | IMAIKENA ONCOLOGY INC | 6,368,587 | $11.0B | 200.19% | |
| 79 | ABCLABCELLERA BIOLOGICS INC | 4,180,768 | $10.9B | 197.51% | |
| 80 | PMVPPMV PHARMACEUTICALS INC | 6,475,291 | $9.6B | 175.31% | |
| 81 | AVTXAVALO THERAPEUTICS INC | 967,000 | $9.2B | 166.92% | |
| 82 | VSTMVERASTEM INC | 2,862,448 | $8.6B | 155.51% | |
| 83 | LYELLYELL IMMUNOPHARMA INC | 6,086,001 | $8.4B | 152.61% | |
| 84 | OSCROSCAR HEALTH INC | 351,618 | $7.5B | 135.51% | |
| 85 | BCAXBICARA THERAPEUTICS INC | 271,910 | $6.9B | 125.84% | |
| 86 | PASGPASSAGE BIO INC | 9,822,876 | $6.9B | 124.94% | |
| 87 | PEPGPEPGEN INC | 797,358 | $6.8B | 123.87% | |
| 88 | NKTXNKARTA INC | 1,480,600 | $6.7B | 121.60% | |
| 89 | MRNAMODERNA INC | 100,000 | $6.7B | 121.43% | Call |
| 90 | —IKENA ONCOLOGY INC | 3,539,358 | $6.1B | 111.26% | |
| 91 | AM6AMICUS THERAPEUTICS INC | 570,300 | $6.1B | 110.67% | |
| 92 | SRRKSCHOLAR ROCK HLDG CORP | 742,300 | $5.9B | 108.04% | |
| 93 | FATEFATE THERAPEUTICS INC | 1,680,580 | $5.9B | 106.88% | |
| 94 | NSPRINSPIREMD INC | 2,133,405 | $5.7B | 103.89% | |
| 95 | —LONGBOARD PHARMACEUTICALS IN | 170,000 | $5.7B | 102.95% | |
| 96 | TELATELA BIO INC | 2,161,185 | $5.5B | 99.35% | |
| 97 | SOLVSOLVENTUM CORP | 69,300 | $4.8B | 87.79% | Call |
| 98 | ASNSUSDX4 PHARMACEUTICALS INC | 7,133,515 | $4.8B | 86.75% | |
| 99 | KRYSKRYSTAL BIOTECH INC | 23,500 | $4.3B | 77.73% | |
| 100 | ARDTARDENT HEALTH PARTNERS INC | 206,000 | $3.8B | 68.80% |
Page 1 of 2Next